News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer
Kristina Jankovic/X
Jan 20, 2025, 13:56

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:

“DC Approval!! US FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- Breast Cancer previously treated with endocrine and chemotherapy for unresectable, metastatic disease. ”

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Additional Information

cancer Kristina Jankovic OncoDaily Oncology
Special Coverage
Societies
Apr 2, 2025, 14:12
Fellows of ASCO (FASCO) Recipients For Last Quarter
Blog
Apr 2, 2025, 14:05
Isabel Mestres: Incredible work in cancer care in India
Blog
Apr 2, 2025, 13:48
David Planchard: Lung preceptorship leading by Fabrice Barlesi at Gustave Roussy
Blog
Apr 2, 2025, 13:40
Runcie C.W. Chidebe: Creating prostate cancer awareness and urging the government to fund research
Blog
Apr 2, 2025, 13:28
Gratitude for NIH Leaders: Honoring their Dedication and Impact
Blog
Apr 2, 2025, 13:20
Michael Sapienza: National Colorectal Cancer Awareness Month was full of activities
Drugs
Apr 2, 2025, 13:07
Patrick Hwu: Can neoantigen-specific TILs improve immunotherapy for gastrointestinal cancers?
Blog
Apr 2, 2025, 13:00
Annals of Research in Oncology - The new issue is now available
Blog
Apr 2, 2025, 12:56
Ajay Aggarwal: How NATCAN differs from other international audit programs and its future areas for development
Blog
Apr 2, 2025, 12:47
Akhil Santhosh: Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer
Blog
Apr 2, 2025, 12:42
Nick Grant: India trains medics to promote vaccine in huge push to end cervical cancer
Blog
Apr 2, 2025, 12:35
Fumiko Ladd Chino: This JAMA Network Open study is important